Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

XGN

Exagen (XGN)

Exagen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XGN
DateTimeSourceHeadlineSymbolCompany
17/05/202410:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
15/05/202406:25AllPennyStocks.comHealthcare Shares Soar Following Major Price Target IncreaseNASDAQ:XGNExagen Inc
13/05/202423:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XGNExagen Inc
13/05/202423:27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
13/05/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
13/05/202422:00GlobeNewswire Inc.Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full YearNASDAQ:XGNExagen Inc
07/05/202406:05GlobeNewswire Inc.Exagen Announces Campaign for Lupus Awareness MonthNASDAQ:XGNExagen Inc
01/05/202406:05GlobeNewswire Inc.Exagen to Announce First Quarter 2024 Results on May 13, 2024NASDAQ:XGNExagen Inc
26/04/202422:30GlobeNewswire Inc.Exagen Inc. Announces Changes to the Board of DirectorsNASDAQ:XGNExagen Inc
18/03/202423:00GlobeNewswire Inc.Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 ResultsNASDAQ:XGNExagen Inc
18/03/202422:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See UpticksNASDAQ:XGNExagen Inc
09/03/202401:00GlobeNewswire Inc.Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumNASDAQ:XGNExagen Inc
08/03/202408:05GlobeNewswire Inc.Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024NASDAQ:XGNExagen Inc
07/03/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
05/03/202408:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
23/02/202408:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
23/02/202408:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
14/02/202423:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
14/02/202408:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
09/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
03/02/202407:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
31/01/202408:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:XGNExagen Inc
23/01/202408:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:XGNExagen Inc
09/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
08/01/202404:00GlobeNewswire Inc.Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms GuidanceNASDAQ:XGNExagen Inc
12/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
30/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XGNExagen Inc
30/11/202309:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
28/11/202308:05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:XGNExagen Inc
21/11/202300:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN